A Randomized Study of Peri-Operative Chemotherapy in Patients with Completed Resected Non-Small-cell Lung Cancer
Zhiwei Chen,Meilin Liao,Jiaan Ding,Shun Lu,Zhen Zhou,Baijun Cheng
DOI: https://doi.org/10.3969/j.issn.1007-3639.2005.03.007
2005-01-01
Abstract:Purpose:To evaluate the effect of cisplatin-based peri-operation chemotherapy (CT) on survival after completed resection of non small cell lung cancer (NSCLC)Methods:A prospective, randomized, multicenter study was conducted by Shanghai Lung Cancer Team since Feb 1995 to Dec 2003 for stage Ⅰ~ⅢA NSCLC with completed resection. Patients were randomly assigned to receive pre-operative CT or no pre-operative CT (pre-op CT). Post-operative CT (post-op CT) were used for majority of the patients, except for partial stage I patients. Accumulated survival, log rank, MST, Cox uni-variance and multi-variance analyses, HR were used as statistics for evaluation Results:A total of 337 patients underwent randomization, 169 cases received pre-operative CT, and 168 cases didn't receive pre-operative CT. There was statistical survival difference between the group with no pre-op CT and with pre-op CT, 5-yr survival rate were of 47.85%∶ 36.52%, MST were 56.63∶39.14(P=0.03), respectively. Stage and post-op CT were the only two meaningful parameters with statistical survival difference calculated by multi-variance analyses (P0.01), but no difference was found in others 4 parameters (age, sex, type and pre-op CT). In various stage, a statistical survival difference was only shown in stage Ⅱ NSCLC,(P=0.02), 5-yr survival rate and MST were worse in the group with pre-op CT, 28.50%∶58.91% and 35.38 months∶60 months, respectively, but no difference was seen in stage I and stage ⅢA NSCLC. There was no statistical progression-free survival (PFS) difference between the group with no pre-op CT and with pre-op CT (P=0.10), Stage and post-op CT were two meaningful parameters with statistical PFS difference calculated by multi-variance analyses,HR=2.08 and 0.86, respectively. Stage Ⅱ patients assigned to no pre-op CT had a significantly higher PFS rate than those assigned to pre-op CT (P=0.03), but no difference was seen in stage I and ⅢA NSCLC(P0.05). There were 121 cases received more than 3 cycles post-op CT, 216 cases received less than 3 cycles post-op CT. The patients received more than 3 cycles had better yr-survival and MST than those received less cycles (P=0.04).Post-op CT was not benefit to the survival rate of stage I. In stage Ⅱ and ⅢA ,the patients received ≥3 cycles post-op CT had better yr-survival than those received less cycles(P0.01). From Cox multi-variance analyses, stage and post-op CT were the only two meaningful parameters with statistical survival difference (P0.01). In the cases with pathological ‘T’ down stage and ‘T’ unchanged after pre-op CT had a better yr-survival rate and MST than ‘T’ up-stage, effective chemotherapy might be beneficial to survival. Besides, in the cases with ≥3 cycles of post-op CT have better survival rate than less cycles Conclusions:There was statistical survival difference between the group with no pre-op CT and with pre-op CT in stage I and ⅢA ,but in stage Ⅱ NSCLC, the yr-survival rate was worsen in pre-op CT arm. From multi-variance Cox analyses, more than 3 cycles post-op CT had a better statistical yr-survival than less cycles, more than 3 cycles post-op CT was preferred